Oct 9, 2026 09:05AM
Oct 9, 2026 09:05AM
Aug 6, 2026 04:03PM
Jul 14, 2026 06:57AM
Jul 13, 2026 09:05AM
Jul 13, 2026 09:05AM
Feb 25, 2026 08:20AM BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $94 at Bernstein
Feb 23, 2026 04:05PM
Oct 29, 2025 09:01AM
Oct 29, 2025 09:00AM
Oct 28, 2025 09:23AM
Oct 28, 2025 08:43AM
Aug 26, 2025 06:35AM
Jul 15, 2025 06:15AM Wolfe Research Reiterates Outperform Rating on BioMarin Pharmaceutical Inc. (BMRN)
Jun 25, 2025 10:03AM
Apr 10, 2025 05:32AM
Sep 21, 2023 10:00AM
Sep 15, 2023 09:29AM
Sep 15, 2023 09:29AM
Jun 22, 2023 08:00AM
Apr 26, 2023 04:03PM BioMarin Announces Record Breaking First Quarter 2023 Results, Including 15% Year-over-year Growth of Total Revenues
Mar 14, 2023 08:00AM
Mar 7, 2023 04:08PM
Mar 7, 2023 04:05PM
Mar 7, 2023 07:07AM
Mar 6, 2023 07:28PM
Feb 27, 2023 04:03PM
Jan 9, 2023 05:05AM BioMarin Pharma (BMRN) Reports Stable and Durable Annualized Bleed Control for ROCTAVIAN in Phase 3 Study
Jan 8, 2023 11:00AM
Jan 4, 2023 08:39AM
Nov 7, 2022 04:31PM
Nov 7, 2022 04:30PM
Oct 26, 2022 04:03PM
Oct 12, 2022 05:12PM
Oct 12, 2022 04:05PM BioMarin Pharma (BMRN) Announces FDA Accepts BLA for Valoctocogene Roxaparvovec AAV Gene Therapy for Adults with Severe Hemophilia A
Oct 12, 2022 04:05PM
Feb 9, 2022 08:31AM
Feb 9, 2022 08:31AM
Oct 28, 2021 06:20AM
Oct 27, 2021 04:05PM
Aug 27, 2021 09:51AM
Aug 27, 2021 09:02AM BioMarin Pharma (BMRN) Announces European Commission Approves VOXZOGO for Treatment of Children with Achondroplasia from Age 2 Until Growth Plates Close
Aug 27, 2021 09:01AM
Aug 24, 2021 07:20AM
Jul 28, 2021 04:03PM
Jun 25, 2021 07:30AM
Jun 25, 2021 07:29AM
Jun 22, 2021 07:15AM
Apr 29, 2021 04:03PM BioMarin Announces First Quarter 2021 Financial Results and Corporate Updates
Apr 15, 2021 08:35AM

15,992 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All